Non-Antibody Products — page 1 of 143
Non-Antibody Products
Page 1 of 143
| Name | Description | Size | Catalog # | Supplier | |
|---|---|---|---|---|---|
| Lipid A4 | delivery of mRNA; LNPs containing lipid A4 and encapsul… | 1 mg | 38351-1 |
 CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A4 | delivery of mRNA; LNPs containing lipid A4 and encapsul… | 10 mg | 38351-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A4 | delivery of mRNA; LNPs containing lipid A4 and encapsul… | 5 mg | 38351-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A6 | LNPs to deliver mRNA; LNPs containing lipid A6 and enca… | 10 mg | 35052-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A6 | LNPs to deliver mRNA; LNPs containing lipid A6 and enca… | 25 mg | 35052-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A6 | LNPs to deliver mRNA; LNPs containing lipid A6 and enca… | 5 mg | 35052-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A6 | LNPs to deliver mRNA; LNPs containing lipid A6 and enca… | 50 mg | 35052-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A9 | An ionizable cationic lipid (pKa = 6.27); has been used in combin… | 10 mg | 37667-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A9 | An ionizable cationic lipid (pKa = 6.27); has been used in combin… | 25 mg | 37667-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A9 | An ionizable cationic lipid (pKa = 6.27); has been used in combin… | 5 mg | 37667-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A9 | An ionizable cationic lipid (pKa = 6.27); has been used in combin… | 50 mg | 37667-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| LIPID A6 | Alkyne lipid A6 demonstrated a significant impr… | 25 mg, 100 mg, 50 mg | orb1473188 |
 BIORBYT LTD. |
More Info |
| Lipid A9 | Lipid A9 is a is a novel cationic … | 50 mg, 25 mg, 100 mg | orb1146695 |
BIORBYT LTD. |
More Info |
| C12-4 (Lipid A4,Lipid A-4) | Lipid A4 (C12-4) is a branched-chain ionizable… | 25 mg | orb1818901 |
BIORBYT LTD. |
More Info |
| Lipid A Salmonella (Highly Pure) | ]-alpha-D-Glucopyranose 1,4'-Diphosphate Other name(s): Lipid | n/a |
MDP0894 |
|
 MOLECULAR DEPOT
More Info
|
|
| Kdo2-Lipid A | Structural Formula: C110H198N2Na4O39P2, Molecular Weight: 2326.64, | 1 mg | sc-396556 |
 SANTA CRUZ BIOTECHNOLOGY INC. |
More Info |
| Lipid A (E. coli) Highly Pure Compound | Lipid A (E. coli) is a highly pure fundamental… | n/a | MDP0891 |
MOLECULAR DEPOT |
More Info |
| Kdo2-Lipid A (sodium salt) | -α in RAW 264.7 macrophages at 100 ng / ml; has been used in lipidom… | 1 mg | 10860-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid A1-D1-5 | Lipid A1-D1-5 is a ionizable be used for a<… | 25 mg | orb1568369 |
BIORBYT LTD. |
More Info |
| Lipid A Monophosphoryl from Salmonella minnesota R595 | A TRIF-biased TLR4 agonist; induces T cell clonal expansion and T… | 1 mg | 25848-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Recombinant Haemophilus influenzae Lipid A biosynthesis (KDO)2- (lauroyl)-lipid IVA acyltransferase | Sequence: 1-318aa; full length protein. MW: 36,883 Da | 0.01 mg, 0.05 mg, 0.1 mg | MBS7020962 |
 MYBIOSOURCE INC. |
More Info |
| Recombinant Escherichia coli Lipid-A-disaccharide synthase (lpxB) | Sequence: 1-382aa, full length protein. Purity >85% (SDS-PAGE). MW: 42,414… | 0.05 mg (E. coli), 0.05 mg (Yeast), 0.2 mg (E. coli) | MBS1001854 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Haemophilus influenzae Lipid A biosynthesis (KDO)2- (lauroyl)-lipid IVA acyltransferase | Purity >85% (SDS-PAGE). MW: 36,883 Da | n/a | MBS7060278 |
MYBIOSOURCE INC. |
More Info |
| Lipid III-45 | vivo; LNPs containing lipid III-45 and encapsulating a… | 10 mg | 39243-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid III-45 | vivo; LNPs containing lipid III-45 and encapsulating a… | 25 mg | 39243-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid III-45 | vivo; LNPs containing lipid III-45 and encapsulating a… | 50 mg | 39243-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Recombinant Haemophilus influenzae Lipid A biosynthesis lauroyl acyltransferase (htrB) | Sequence: 1-311aa; full length protein. MW: 36,152 Da | 0.01 mg, 0.05 mg, 0.1 mg | MBS7017342 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Legionella pneumophila Lipid A palmitoyltransferase PagP (pagP) | Sequence: 19-190aa, Full Length of Mature Protein. Purity >85% (SDS-PAGE).… | 0.05 mg (E. coli), 0.05 mg (Yeast), 0.2 mg (E. coli) | MBS1012538 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Lipid A export ATP-binding/permease protein MsbA (msbA) | Sequence: 1-582. Purity ≥90%. MW: 64,461 Da | n/a | MBS1164842 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Haemophilus influenzae Lipid A biosynthesis lauroyl acyltransferase (htrB), partial | Purity >85% (SDS-PAGE). MW: 36,152 Da | n/a | MBS7060774 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Legionella pneumophila Lipid-A-disaccharide synthase 1 (lpxB1) | Sequence: 1-384aa, full length protein. Purity >85% (SDS-PAGE). MW: 42,663… | 0.05 mg (E. coli), 0.05 mg (Yeast), 0.05 mg (Baculovirus) | MBS1344072 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Legionella pneumophila Lipid-A-disaccharide synthase 2 (lpxB2) | Sequence: 1-385aa, full length protein. Purity >85% (SDS-PAGE). MW: 43,707… | 0.05 mg (E. coli), 0.05 mg (Yeast), 0.05 mg (Baculovirus) | MBS1438436 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Alcanivorax borkumensis Lipid A export ATP-binding/permease protein MsbA (msbA) | Sequence: 1-582aa; full length protein. MW: 64,258 Da | 0.01 mg, 0.05 mg, 0.1 mg | MBS7020857 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Klebsiella pneumoniae Phosphoethanolamine--lipid A transferase MCR-8.1 (mcr-8), partial | Recombinant Klebsiella pneumoniae Phosphoethanolamine--lipid … | 20 ug, 100 ug, 1 mg | orb1674546 |
BIORBYT LTD. |
More Info |
| MEL-A | A glycolipid biosurfactant; a mixture of MEL-A… | 100 mg | 33858-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MEL-A | A glycolipid biosurfactant; a mixture of MEL-A… | 25 mg | 33858-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
| MEL-A | A glycolipid biosurfactant; a mixture of MEL-A… | 50 mg | 33858-50 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Recombinant Escherichia coli Phosphoethanolamine transferase eptA (eptA) | Sequence: 1-547aa. Full Length. MW: 61,667 Da | 0.01 mg, 0.05 mg, 0.1 mg | MBS7014302 |
MYBIOSOURCE INC. |
More Info |
| Recombinant Escherichia coli Phosphoethanolamine transferase eptA (eptA), partial | Sequence: 176-547aa. Partial. Purity >85% (SDS-PAGE). MW: 61,667 Da | 0.05 mg (E-Coli), 0.05 mg (Yeast), 0.2 mg (E-Coli) | MBS7060548 |
MYBIOSOURCE INC. |
More Info |
| MPLA | A synthetic derivative of lipid A; a T… | 100 µg | 25998-100 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Recombinant Salmonella typhimurium Phosphoethanolamine transferase eptB (eptB), partial | Purity >85% (SDS-PAGE). MW: 64,001 Da | n/a | MBS7060708 |
MYBIOSOURCE INC. |
More Info |
| LpxT Peptide | n/a | 0.05 mg | orb1787771 |
BIORBYT LTD. |
More Info |
| Lipid 10a-26 | MW: 802.31 | 25 mg | orb1568367 |
BIORBYT LTD. |
More Info |
| Recombinant Escherichia coli Tetraacyldisaccharide 4-kinase (lpxK) | 4100 / BW2952). Target Name: lpxK. Target Synonyms: Lipid A
| 20ug, 100ug, 1mg |
RPC27327 |
|
 BIOMATIK
More Info
|
|
| Lipid Catechol | A lipid used in the formation of lipid prodrug… | 1 mg | 38665-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid Catechol | A lipid used in the formation of lipid prodrug… | 10 mg | 38665-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid Catechol | A lipid used in the formation of lipid prodrug… | 5 mg | 38665-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 331 | administration of LNPs containing lipid 331 and DOTAP and encaps… | 1 mg | 39771-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 331 | administration of LNPs containing lipid 331 and DOTAP and encaps… | 10 mg | 39771-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
| Lipid 331 | administration of LNPs containing lipid 331 and DOTAP and encaps… | 5 mg | 39771-5 |
CAYMAN CHEMICAL COMPANY |
More Info |